Clinical trial Recruiting at 5 sites Interventional Ages 18 and up

Evaluating HeartLogic Management for Heart Failure Outcomes

Official title: Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes

Run by Herlev and Gentofte Hospital · NCT06099158 · Data updated 2026-11-12

This study tests if using HeartLogic technology to manage heart failure can help patients with implanted devices do better compared to standard care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1428 (estimated)
SponsorHerlev and Gentofte Hospital
Academic / other
Locations5 sites (Hellerup, Capital Region and 4 other locations)
StatusRecruiting
StartedMay 31, 2024
Main results expectedDecember 1, 2027
Study endsDecember 1, 2027
Registry record updatedOctober 29, 2026
Trial IDNCT06099158 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have an implanted CRT-D or ICD device with HeartLogic capability.

Probably not a fit

Patients who are not compliant with remote monitoring or are not using a device with HeartLogic capability may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study assesses the impact of HeartLogic-guided management on clinical outcomes in patients with heart failure who have an implanted cardiac device. It is a pragmatic, registry-based, randomized controlled trial conducted in Denmark, where eligible patients will be randomly assigned to either HeartLogic-guided management or usual care. Patients in the HeartLogic group will receive alerts for evaluation and treatment decisions without mandatory in-person visits, while the control group will follow standard heart failure care. Data will be collected from nationwide health registries to evaluate the effectiveness of the intervention.

Why it matters

Potential benefit: If successful, this approach could lead to improved heart failure management and outcomes for patients with cardiac devices.

How similar studies have gone: Other studies have shown promise in using remote monitoring for heart failure management, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Implanted with a CRT-D or ICD device that has HeartLogic capability and ability to change HeartLogic enablement per randomization
2. Age ≥18 years
3. Compliant with remote monitoring and not listed in the LATITUDE™ remote monitoring system as "not monitored"

Exclusion Criteria:

There are no specific exclusion criteria for the trial.

Where it's running

  • Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte
    Hellerup, Capital Region, Denmark
    Recruiting
  • Aarhus University Hospital
    Aarhus, Denmark
    Recruiting
  • Rigshospitalet
    Copenhagen, Denmark
    Recruiting
  • Odense University Hospital
    Odense, Denmark
    Recruiting
  • Zealand University Hospital
    Roskilde, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.